During neo-vascularization, there is a well-defined requirement for the release of angiogenic factors; this is often linked to oxygen deprivation in these tissues. A key effector of this response is the transcription factor HIF-1α. We deleted this factor in endothelial cells to determine its role during induced vascularization, and found that loss of the transcription factor inhibits a number of important parameters of EC behavior during angiogenesis: these include proliferation, chemotaxis, matrix penetration, and wound healing. Most strikingly, loss of HIF-1α in endothelial cells results in a profound inhibition of blood vessel growth in solid tumors. These phenomena are all linked to a decreased level of VEGF expression, and autocrine control of the VEGF receptor VEGFR-2 in HIF-1α null endothelial cells. We demonstrate here that VEGF null endothelial cells have similar defects in VEGFR-2 up-regulation during hypoxia, but that HIF-1α null endothelial cells are specifically deficient in VEGF-induced chemotaxis.
Introduction
Angiogenesis, the formation of new capillaries from existing blood vessels, is required for processes ranging from placental invasion to organogenesis during embryogenesis, and from wound healing to endometrial growth in adults [1] . It is also an essential aspect of a number of pathologies involving new tissue growth; including the growth of solid tumors, which require angiogenesis for expansion and metastasis [2] .
Angiogenesis can be stimulated by lowered physiological oxygen, or hypoxia. Hypoxia in wound healing, during cardiovascular and cerebral ischemia, and in solid tumor formation induces the increased expression of a number of factors key to mobilizing endothelial cell chemotaxis and proliferation [3, 4] . The hypoxia-inducible transcription factor-1 (HIF-1) acts to control induced expression of many, if not most, hypoxiainducible genes, and it is clear that HIF-1 is essential for hypoxia-induced increases in glycolysis and angiogenesis in tumor cells, as well as normal tissues [5, 6] .
The vascular endothelial growth factor (VEGF) is an essential regulator of vascularization [7] . VEGF acts on endothelial cells as both a chemotactic, and mitogenic factor, via endothelial cell-specific receptors: VEGFR-1 (Flt-1), VEGFR-2 (Flk-1/KDR) and VEGFR-3 (Flt-4) [8] . VEGFR-2 is a major mediator of mitogenic, angiogenic and permeability-enhancing effects of VEGF [9, 10] , although the precise function of VEGFR-1 in angiogenesis is still under debate [8, 11] . During early embryonic development, VEGFR-1 has been suggested to be a negative regulator of VEGF action [12] , while in adult animals, other studies indicate that VEGFR-1 is a regulator of VEGF action [12, 13] ; VEGFR-3 is primarily expressed in lymphatic endothelial cells, and is Tang, et al.: HIF-1 null endothelial cells lack proper autocrine response thought to be primarily a regulator of lymphatic angiogenesis [14] . The expression of VEGFR-1 and VEGFR-2 are upregulated by hypoxia; VEGFR-1 is directly up-regulated by hypoxia, via a HIF-1 binding enhancer element located in the VEGFR-1 promoter, while the upregulation of VEGFR-2 by hypoxia is mediated by posttranscriptional regulation [15, 16] .
These data indicate that endothelial cells have the potential to tightly regulate their hypoxic responses in coordination with changes in the oxygenation of surrounding tissues. The post-transcriptional regulation of VEGFR-2 is tied to VEGF expression; this has been shown in a variety of experiments, including those which demonstrated that paracrine media from hypoxia-induced cell cultures caused increased VEGFR-2 expression [17] , that hypoxia itself could increase expression of the receptor [18, 19] , and that this could function in the fashion of an autocrine loop [20] . This last finding was shown by Jain and colleagues to be related directly to the formation of tubes and networks of endothelial cells during hypoxia [21] . What remains undefined is the role of specific interactions between hypoxic response, HIF-1 activation, VEGF expression and VEGFR-2 response in vivo, particularly during tumorigenesis.
Tang, et al.: HIF-1 null endothelial cells lack proper autocrine response 5 There are clearly many potential aspects of endothelial cell function that could require hypoxic response through the HIF-1 pathway; but it is unclear how and to what extent this pathway regulates EC in vivo, and how the importance of that response stands in contrast to the hypoxic response from the cells and tissues in which the vasculature is located. This is a pressing issue in tumor formation, in that it is not clear how tissues interact with EC during hypoxia to mobilize and accomplish neo-vascularization.
We have specifically removed HIF-1α from endothelial cells, and show here that angiogenesis in vivo is impaired by loss of HIF-1α in EC, demonstrating that HIF-1α is critical for EC function during neo-vascularization. We demonstrate that this impairment is a direct result of the disruption of an autocrine loop, acting through HIF-1α regulation of hypoxia-induced VEGF expression.
RESULTS

HIF-1α is required for hypoxia-inducible gene transcription in murine endothelial cells
To determine if HIF-1α is expressed in primary EC in a hypoxia-dependent manner, EC from conditionally targeted mice were purified from lung and then cultured under normoxic, hypoxic and anoxic conditions; 72 hours prior to hypoxic culture, cells were infected with Cre recombinase-expressing adenovirus to induce deletion of the conditional allele of HIF-1α; wild type cells were infected with a control adenovirus.
Nuclear and cytosolic extracts were assayed for HIF-1α protein expression: as shown in Figure 1A , only non-specific signals, and not HIF-1α protein can be detected in cytosolic Tang, et al.: HIF-1 null endothelial cells lack proper autocrine response extracts, and in EC, there was only a weak induction of HIF-1α protein during hypoxic culture (0.5% O 2 ). Much more nuclear induction of HIF-1α was observed in response to culture under anoxic conditions in wild type cells ( Figure 1A ).
It has been shown that HIF-1α is ubiquitously transcribed, but that the primary site of mRNA expression of the highly related transcription factor HIF-2α is the endothelium [22] [23] [24] [25] . To determine the level of redundancy of HIF-1α in EC, and to determine if HIF-1α alone is essential for hypoxia-induced transcription in endothelial cells, the expression levels of three known HIF-1 targets were assayed in these cells: the glycolytic enzyme phosphoglycerate kinase, PGK, the glucose transporter GLUT1, and VEGF following purification of endothelial cells from lungs of conditionally targeted animals (purification levels shown in Figure 1B ). The mRNA expression levels were compared in primary cultures of wild-type and HIF-1α -/-mEC, cultured at normoxia or hypoxia. The hypoxiainducible expression of PGK, GLUT1 and total VEGF was reduced significantly by loss of HIF-1α ( Figure 1C) , in a manner similar to that seen in other tissues without HIF-1α [26] . This indicates that HIF-2α and/or other hypoxia-induced factors cannot act in such a way as to make HIF-1α completely redundant in endothelium.
Intracellular ATP levels are regulated by HIF-1α
To determine the role of HIF-1α in regulation of EC energy metabolism, we assayed ATP production by primary EC. After the EC were cultured for 24 hours under normoxia and hypoxia, whole cell extracts were prepared to compare the levels of free ATP in the cultured cells. The amount of free ATP produced by each cell line was normalized for protein levels within each whole-cell lysate. As shown in Fig. 1D , the total amounts of Tang, et al.: HIF-1 null endothelial cells lack proper autocrine response 7 free ATP produced during hypoxia was dependent on the HIF-1α status of the EC.
Interestingly, under hypoxic conditions, free ATP increased about 1.6-fold in wild-type EC, while in null EC the level of free ATP was slightly decreased. The reduction of cellular ATP in the HIF-1α null EC indicate that HIF-1α activity helps to maintain intracellular ATP at wild type levels in endothelial cells under these hypoxic, albeit normoglycemic, conditions.
Conditional deletion of HIF-1α in vivo by bone marrow transplantation
We created a conditional deletion of the HIF-1α transcription factor in endothelial cells in vivo via crosses into a background of cre recombinase expression driven by the Tie2 promoter, which allows specific deletion in the endothelium [27] . It has been shown that the Tie2-cre transgenic mouse line facilitates cre recombinase expression in endothelial cells and in hematopoietic cells [28] . Here we also found high efficiency of recombination (approximately 98%) in cells from the bone marrow isolated from Tie2 cre/HIF-1α conditionally null mice (Fig. 1E, grey bar) . To create endothelial cell-specific HIF-1α null mice, we performed bone marrow reconstitution to rescue the deletion of the HIF-1α gene in hematopoietic cells (Fig. 1D) . After a lethal dose of radiation, wild type and null littermates were intravenously injected with bone marrow cells. 8 weeks after bone marrow transplantation, the deletion efficiency of the HIF-1α gene was tested by real time PCR of genomic bone marrow cells. More than 80% of the hematopoietic cells were recovered as wild type (Fig. 1E) . Tie2-cre (null) mice [27] . This is a well-established in vivo angiogenesis model; the level of angiogenesis is typically viewed by embedding and sectioning the plugs in paraffin and staining using Masson's Trichrome [29] . Matrigel plugs containing recombinant murine VEGF at 20ng/ml are implanted subcutaneously in the flanks of bone marrow-rescued Tie2cre/HIF-1α conditional mice and controls; 8 days after implantation, the matrigel plugs were removed and analyzed. The matrigel plugs removed from wild type mice ( Figure 2A) were yellowish, an initial gross indication of significant angiogenesis.
Masson's trichrome staining showed that there were considerable numbers of vessels in the plugs ( Figure 2C ). The plugs removed from HIF-1α +f/+f Tie2-cre (null) mice were relatively colorless ( Figure 2B ). At higher magnification, it was clear that the vessels in matrigel plugs contained erythrocytes, indicating that they had formed functional capillaries (black arrows in Figures 2E, 2F ). When viewed by Masson's trichrome staining, there was a 40% reduction in blood vessel density by Chalkley counting and in addition, most of the vessels only migrated to the edge of the matrigel plugs ( Figures 2D,   2G ). These results demonstrate that loss of HIF-1α in endothelial cells disrupts VEGFdependent signaling pathways in vivo.
HIF-1α EC null mice exhibit delayed wound healing
Tang, et al.: HIF-1 null endothelial cells lack proper autocrine response New microvascular network formation is a critical component of wound healing [30, 31] .
Numerous new capillaries carry oxygen and nutrients to sustain the metabolism that is needed during the healing process [31] . During wound healing, endothelial sprouts are induced by angiogenic factors; these sprouts then migrate into avascular zones to reestablish connection with the circulation [31] . EC response to hypoxia is thus likely one of the key responses in the process of wound healing. To determine the amount of hypoxia in early stages of cutaneous wound healing, the hypoxic areas of the wounds were visualized in pimonidazole-treated mice using the hypoxyprobe-1 monoclonal antibody. As can be seen in Figure 3A , there is a significant degree of hypoxia at the wound margin in experimental wounds (brown staining at wound margin).
To determine rates of wound closure, we performed three 6mm circular punch biopsies on the back skin of each of ten HIF-1α wild type and HIF-1α EC null littermates after recovery from bone marrow transplantation, and measured wound closure daily over a 12-day period. As shown in figure 3B , wound healing was significantly delayed in the HIF-1α +f/+f Tie2-cre EC null mice compared with wild-type littermates (* p< 0.05, **p< 0.01 at day 3, 4, 5, 6, 7). Histological changes in early stage wounds were examined by H&E staining. At day 6 post-injury, the epidermis of wild type wounds deeply migrated under the fibrin clot ( Figure 3C ), while the leading epidermal edge of EC null wounds did not clearly invade into the fibrin clot, and remained at the wound margin at this stage of healing ( Figure 3D ).
At very early stages of wound healing, new capillary sprouts develop from dilated vessels adjacent to the wounds, and invade the wound clot [32, 33] . To determine the amount of Tang, et al.: HIF-1 null endothelial cells lack proper autocrine response capillary formation in wound healing, we detected endothelial sprouting by immunostaining; at day 2 post-injury, new capillary sprouts of wild type wounds emanated from the dilated vessels adjacent to the wounds ( Figure 3E ). These wild type vessels invaded the wound fibrin clot, and migrated to the leading epidermis of the wounds (arrow indicates the direction of vessel migration). In the wounds of HIF-1α +f/+f Tie2-cre EC null mice, there were fewer new capillaries emanating from tissues adjacent to the wounds (Fig 3F and graph, Figure 3G ). These assays demonstrate that loss of HIF-1α in endothelial cells results in abnormal angiogenesis of wounds, which leads in turn to a delay in healing.
Reduced tumor size and severely necrotic tumors in HIF-1α EC null mice
Tumors typically initiate as small avascular masses, and can develop a severely hypoxic microenvironment; this subsequently can act to help induce the angiogenesis that is required to allow further tumor growth [2, [34] [35] [36] . The regulation of angiogenesis by hypoxia is an important link between vascular oxygen supply and tumor metabolic demand. We performed a standard assay of tumorigenesis to determine whether the defects in null EC would affect tumor growth. Lewis lung carcinoma cells will grow in immunocompetent C57Bl6 mice [37] ; and so were injected subcutaneously into the HIF-1α wild type and HIF-1α +f/+f Tie2-cre EC null mice after bone marrow transplantation.
Tumors from HIF-1α +f/+f Tie2-cre EC null mice only reached 60% the weight of tumors from wild type mice at 15 days post-injection ( Figure 4A ). In addition, the tumors removed from EC null mice showed severe central necrosis ( Figure 4C ), while much smaller necrotic areas were seen in the tumors removed from wild type mice ( Figure 4B ).
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We next analyzed microvessel density (MVD) in these tumors. Vessels were visualized by immunostaining with anti-CD31 antibodies, and the density of the vessels calculated by Chalkley counting as described previously [38] . 
HIF-1α regulates proliferation of endothelial cells during hypoxia
The hypoxia-induced mitogenic response is one of the key steps in endothelium-driven neo-angiogenesis during hypoxic stress [4, 39] . Previous data from our laboratory demonstrated that transformed cell growth is deficient in cells lacking HIF-1α, particularly under hypoxic conditions [26] . To determine the extent to which [26] HIF-1α was required during hypoxic growth of EC, we evaluated growth rates following loss of HIF-1α in immortalized EC lines.
We isolated mEC lines from animals with a conditional mutation in HIF-1α. These animals were also homozygous for a deletion of the p53 gene, allowing rapid outgrowth and EC line establishment. Following establishment, cells were treated with adenovirus expressing Cre recombinase, in order to delete the HIF-1α gene.
As seen in Figure 5A , the mEC cell line lacking HIF-1α (labeled null) was able to grow at approximately the same rate as a wild-type control mEC line (WT) under normoxic conditions. As seen in Figure 5B , wild-type mEC have the same growth rate under hypoxia and normoxia. However, HIF-1α null cells grew more slowly in the exponential phase of culture under hypoxia. As seen in Figure 5C , the growth of both wild-type and null mEC was arrested after 48 hours of culture under anoxic conditions, although the wild type cells still had a significant growth advantage under these conditions.
HIF-1α null EC and VEGF null EC have defects in capillary structure formation on matrigel substratum under hypoxia.
A major attribute of new blood vessel formation is capillary sprouting and tube formation by migrating EC, which may be stimulated by hypoxia [40, 41] , a process thought to be regulated in part by paracrine or autocrine VEGF. A requirement for HIF-1α in motility might be due to a defect in autocrine or paracrine production of VEGF, in a HIF-1α-dependent manner. To determine the extent to which loss of VEGF production affects motility towards VEGF, we isolated and assayed EC from VEGF conditionally deleted animals [42] , in a manner similar to that described for isolation and characterization of HIF-1α null EC.
To determine whether HIF-1α is involved in this process, and the extent to which it might be dependent on VEGF expression induced by hypoxia, we tested the capacity of primary wild type, HIF-1α null, or VEGF null primary EC to organize into tubes in vitro.
Under normoxia, both wild type and, to a lesser extent, HIF-1α and VEGF null EC conditions. We assayed random motility through assays where serum was at high levels in both the upper and lower chamber ( Figure 7B ) and directed motility/chemotaxis, where VEGF was placed only in the lower chamber under low serum conditions ( Figure   7A ).
The motility of both VEGF null and HIF-1α null EC is greatly reduced under hypoxia in the directed assay ( Figure 7A ). However, in an assay of random motility ( Figure 7B ), the HIF-1α null EC are essentially as motile as wild type cells, whereas the VEGF null EC have a greatly reduced level of migration, presumably due to defects in autocrine VEGFinduced cell movement.
Hypoxia-induced expression of VEGF receptors in EC requires HIF-1α
Hypoxia has been proposed to play an important role in the up-regulation of VEGF receptor gene expression. It has been shown that VEGFR-1 is transcriptionally upregulated by HIF-1α under hypoxic conditions [16] , while VEGFR-2 receptor expression is mediated by post-transcriptional mechanisms, such as enhanced protein stability [15] . To investigate the expression of VEGFR-1 and VEGFR-2 in primary wild type and mutant EC, they were cultured under normoxia, hypoxia or anoxia for 24 hours, and total RNA and protein was isolated. The mRNA expression of VEGFR-1 and VEGFR-2 were determined by real time PCR following normalization to 18S rRNA. We found a 2.5-fold increase of VEGFR-1 mRNA in wild type EC under hypoxia, and this hypoxic induction of VEGFR-1 mRNA was partially blocked by the loss of HIF-1α; levels in VEGF null EC were similar to those seen in wild type cells ( Figure 7C ). This was correlated with protein expression levels of VEGFR-1, which were up-regulated under hypoxia and anoxia in wild type and VEGF null EC, but not in HIF-1α null EC (data not shown). VEGFR-2 mRNA levels were decreased slightly in HIF-1α and VEGF null EC under normoxic conditions.
In wild type EC, the protein expression levels of VEGFR-2 were increased about 2.5-fold by hypoxia, while in both HIF-1α null and VEGF null EC VEGFR-2 levels were not changed by culture in hypoxia ( figure 7D ). These results demonstrate that loss of HIF-1α induction/regulation of EC-produced VEGF disrupts an autocrine loop, interrupting increased expression of VEGFR-2 caused by increased VEGF expression.
Discussion
There is a great deal of experimental evidence that the growth of transformed cells in vivo requires a hypoxic response; and that this occurs primarily through the action of HIF-1α [43] . Recent data from our group has also demonstrated that there is a site-specific aspect for the requirement for HIF-1α in malignant cells, where the vascular network available at the site of tumor growth is a critical determinant of the overall rate and invasiveness of tumorigenic progression [44] . The data presented here argue that targeting of HIF-1α response in the endothelium also has to be taken into account, and may be as potent a factor in determining tumor growth as the HIF-1α response in the transformed cell, particularly insofar as it regulates the hypoxia-induced VEGF autocrine loop.
Endothelial cells are able to withstand large fluxes in oxygen and maintain physiological integrity; this presumably allows them to migrate into hypoxic and even anoxic sites during wound healing to re-establish oxygenation [45, 46] . As part of the response to hypoxia, all cells require a robust capacity for anaerobic generation of energy, and endothelial cells are particularly dependent on the glycolytic pathway [47] . We describe here that loss of HIF-1α has a deleterious effect on hypoxic ATP levels in primary endothelium. This likely gives rise to alterations in the overall capacity of the endothelium to chemotax and invade into tissues where oxygen levels are limited, although our data indicate that random motility of the cells is not affected during hypoxia. How pharmacological alterations in endothelial cell hypoxic metabolism might affect tumor growth, and other pathologies where endothelial cell function is critically dependent on glycolysis, remains to be seen.
A possible mechanism to compensate for the absence of HIF-1α is the redundancy of the HIF-1 pathway. A close homolog of HIF-1α, HIF-2α, has been connected in the literature extensively to endothelial cells, and in fact was labeled endothelial PAS protein-1 (EPAS1) by one of the groups that first cloned this transcription factor [22] [23] [24] [25] .
HIF-2α is highly expressed in endothelial cells in vivo, but can be found in a wide range of other cell types as well. Its function, however, is generally unclear, although one recent paper has shown that HIF-2α has a role in regulating the response to oxidative stress [48] . We have shown previously that in cells lacking HIF-1α, HIF-2α is unable to compensate during hypoxic stress; this appears to be due to a cytoplasmic segregation of the HIF-2α protein, which is refractory to hypoxia [49] . We see no compensation in hypoxic response in HIF-1α null endothelial cells in this study, relative to other HIF-1α null cell types, arguing against a specific role for HIF-2α in endothelial cell hypoxic response. It remains to be determined how HIF-2α regulates endothelial cell response to
hypoxia, or what its exact role is, given the evidence for its EC-specific expression.
Cutaneous wound healing requires a coordinated migration of endothelial cells into the wound margin, and a subsequent reorganization of the EC, with a concomitant formation of new capillaries to reestablish circulation under the re-formed epithelial layer [30, 31, 50] . We have shown that HIF-1α-mediated endothelial cell function is essential to the early events in this process, but that the absence of HIF-1α can be compensated for in later stages of wound healing, at least to some extent. However, some wounds in HIF-1α EC null animals remain unhealed for long periods; and the resolution of these wounds is also typically less successful than is the case in wild type animals (N.T. and R.S.J., unpublished observation). This argues that endothelial cell migration stimulated by hypoxia is required for successful resolution of wound healing, and not just for the initial process of re-epithelialization. Our finding of hypoxia at the wound margin indicates that this in turn is a key triggering event leading to the stimulation of wound neovascularization [51] . An important aspect of understanding hypoxic response in wound healing will be to determine whether it is the hypoxia-regulated VEGF autocrine loop acting at the wound margin that is key. Certainly, the role of hypoxic response of other cell types involved in cutaneous wound healing, including the infiltrating leukocytes, and the keratinocytes themselves, will need to be investigated to get a complete picture of hypoxic response and wound healing.
Loss of HIF-1α in all tissues results in an early embryonic lethality, with significant deficits in embryonic and yolk sac vascularization [5, 6] . Capillaries in the global HIF-1α ko are largely absent in embryos, and are disorganized in the embryonic yolk sac of the HIF-1α null mutants [5, 6] . The normal development of the HIF-1α EC null mice indicates that the defects in capillarization seen in early mutant embryos may be due to changes in the hypoxic response of the underlying tissues, and not in the EC. It is an interesting aspect of this mutation, that there is a profound effect on wound healing and tumorigenesis, but no discernible effect on normal vascularization during development.
Further work will be needed to determine if there are more subtle effects on developmental vascularization caused by deletion of EC HIF-1α.
Perhaps most strikingly, we have found that the loss of the hypoxia responsive transcription factor HIF-1α severely alters the morphology, vascularization, necrosis, and growth of tumors. These data demonstrate that loss or inhibition of hypoxic response as a component of cancer therapy may need to target endothelium in the first instance, where it may indeed be more efficacious then the targeting of that response in malignant cells themselves. In addition, the overall normal viability, and lack of overt phenotype, in uninjured mice with HIF-1α null endothelium demonstrates that inhibition of the transcription factor should not adversely affect the health of treated patients, if the treatment itself is targeted to EC.
Further experiments on tumor growth in different sites in this model are critical; they will help determine how tumorigenesis is affected by endothelial response when the endothelial network itself is handicapped in its hypoxic response. In addition, the use of this model in conjunction with tumor cells that lack HIF-1α, or lack one of its targets, such as VEGF, will help to model targeted treatments much better than currently experimentally possible. In such experiments, it will be possible to assess affects on both transformed cells, and critical stromal compartments. In this way genetic models can be created that more truly mimic the pharmacology of inhibited hypoxic response.
In summary, we have shown that loss of HIF-1α or VEGF in EC interrupts an autocrine loop necessary for the post-transcriptional hypoxic induction of VEGFR-2 expression.
This demonstrates that loss of HIF-1α affects function of EC during their directed migration towards regions of hypoxia and, thus, higher levels of VEGF. This feedback mechanism of hypoxic response in EC is necessary for the proper neo-vascularization of wounds and the growth of one type of experimental solid tumor, and indicates that HIF-1α-directed hypoxic response can be critical in indirect as well as direct control of cellular responses in vivo.
Materials and methods
Animals
Animals were housed in an AAALAC-approved facility in filter topped cages and provided with food and water. All animal experiments were conducted using the highest standards for humane care in accordance with the NIH Guide for the Care and Use of Laboratory Animals. Endothelial cell-specific inactivation of HIF-1α was achieved by cross-breeding Tie2-Cre transgenic mice [27] with mice harboring two alleles of exon2 of HIF-1α flanked by loxp sites (HIF-1α +f/+f ) [5] were bred to transgenic mice expressing Tie2-cre. In all experiments, littermates from the same breeding pair were used as controls.
In vitro endothelial cell culture
Mouse lung endothelial cells were isolated from HIF-1α +f/+f mice, VEGF +f/+f mice or p53-/-HIF-1α +f/+f mice and cultured as described in details previously [52] . The cells were characterized by FACScan analysis with endothelial cell specific marker, CD31 to make sure over 95% cell population are endothelial cells. At 80% confluence, endothelial cells were infected overnight with Adenovirus-galactosidase or Adenovirus-cre (from Dr.
Frank Giordiano) at a multiplicity of infection of 100 particles per cell. The next day, the cells were washed several times with PBS and fresh medium was added. After 48 hours infection, the deletion efficiencies of Adeno-β-gal infected (HIF-1α wt) and Adeno-cre infected (HIF-1α null) ECs were checked by Taqman real time PCR before proceeding to any experiments. The sequences of primer and probe are: HIF-1α forward 5'-
CTATGGAGGCCAGAAGAGGGTAT-3', HIF-1α r e v e r s e 5 ' -C C C A C A T C A G G T G G C T C A T A A -3 ' , H I F -1 α p r o b e 5 ' -( 6 F A M )
AGATCCCTTGAAGCTAG (MGBNFQ)-3'. The degree of excision was calculated by comparison of HIF-1α intact DNA relative to an unexcised gene.
Preparation of RNA and DNA
Primary endothelial cells were cultured under normoxic (20% O2) or hypoxic (0.5% O2)
conditions for 8 hours. After that, cells were washed twice with cold PBS before being directly extracted with a Qiagen Rneasy kit for total RNA preparation followed by manufacturer's protocol. For genomic DNA extraction, the cells were lysed with proteinase K in buffer and then phenol-cholorform extracted.
Quantitative realtime PCR analysis
One microgram of total RNA was used to synthesize the first strand CDNA from random hexamer primers using SUPERSCRIPT G l u t -1 :
V E G F R -2 :(F) 5 ' -G G A G A A G A A T G T G G T T A A G A T C T G T G A -3 ' ; (R) 5'-ACACATCGCTCTGAATTGTGTATACTCT-3'; Probe 5 ' -( 6~F A M ) CATCTCCTTTTCTGACATAATCCGGGTCTTTATAAATGTC(BHQ~6~FAM)-3'
Nuclear extract preparation and Western bolt analysis
HIF-1α wild type and HIF-1α null endothelial cells were cultured in under normoxic (20% O2), hypoxic (0.5% O2) or anoxic (0%) condition for 22 hours. After that, cells were washed twice with cold PBS before being directly extracted for protein.
Cytoplasmic extracts (CE) and nuclear extracts (NE) were prepared as described previously [5] . HIF 1α protein was detected by western blotting using 30ug input of CE and NE resolved by a 3-8% SDS-PAGE gel and transferred to PVDF membrane. The membrane was block for 1 hour at room temperature in 5% nonfat dry milk, followed by O/N incubation at 4°C in a 1:500 dilution of anti-mouse HIF1α antibody (gift from Abraham lab). The blot was then incubated in a 1:10,000 dilution of anti-rabbit whole IgG-HRP for 1 hour at room temperature followed by incubation in ECL Plus substrate 
Growth curves
Triplicate plates of p53-/-HIF-1α wt and p53-/-HIF-1α null ECs were seeded in DMEMhigh-glucose medium, supplemented with 10% fetal bovine serum (FBS) and 25mM HEPES (pH 7.4). The next day, following plating, the cells were left under normoxia or transferred to the hypoxic and anoxic chambers, (0 hour). During the experiments, the cell culture medium was not changed. Cells were harvested every 24h by trypsinization.
At least 100 cells from each plate were counted by hemocytometer, and the average cell number per treatment was determined. All growth assays described were repeated three times and the values described in the figures are representative of one triplicate culture experiment ± the standard error of the mean (SEM).
Measurement of intracellular ATP
HIF-1α wt and HIF-1α null primary ECs were cultured under normoxia and hypoxia for 24 hours. Cells were harvested and cellular ATP content was determined using the CLSII Assay Kit (Boehringer-Mannnheim, Germany) as described in detail previously [26] .
Endothelial cell migration assay
The migration of primary endothelial cells was tested by using COSTAR transwells with 
In vitro matrigel tube formation
Growth factor reduced matrigel 10mg/ml (BD Biosciences, Bedford, MA) was applied at 300 ul/well of 24 well plates and incubated at 37°C for at least 1 hour to allow harden. Incubate the plates at 20% or 0.5% oxygen conditions at 37°C for 8 hours. Photographed the results at 40X using a digital camera with at least three pictures per well. The assays were repeated at least three times. The pictures described in the figures are representative of one experiment. Bar data was expressed as one duplicate culture experiment ± the standard error of the mean (SEM).
Quantification of VEGF in conditioned medium
Secreted VEGF was determined by using the DuoSet ELISA development kit for mouse VEGF (R&D Systems, Minneapolis, MN). ELISA analysis was performed according to the manufacturer's instructions.
Bone marrow transplantation (reconstitution) experiments
Since Tie2 promoter/enhancer drived cre can also delete HIF-1α in hematopoietic cells, we performed bone marrow reconstitution experiments based on two permutations of donor and recipient: HIF-1αDF to HIF-1αDF mice (wild type), which served as controls for the effects of radiation and the bone marrow transplantation process; HIF-1αDF to HIF-1αDF tie2-cre (+) mice (EC null), in which HIF-1α is only specifically deleted in endothelial cells but not in recovered bone marrow-derived cells. The mice for these three groups are sex-and age-matched littermates. Littermates were used as donors. In preparation, all recipient mice received two doses of 600rad, 4 hours apart, the same day before intravenous injection of the donor bone marrow. Femora from the donor mice were dissected and flushed with HBSS. The resultant cell suspension was centrifuged at 
In vivo matrigel plugs implantation
In vivo angiogenesis was assayed in mice as growth of blood vessels from subcutaneous tissue into a Matrigel plug containing the test sample, according to Passaniti and colleagues [29] . Growth factor reduced Matrigel (11.1mg/ml) in liquid form at 4ºC was mixed with rmVEGF (20ng/ml) or vehicle alone (Saline containing 0.25% bovine serum albumin). 0.4ml Matrigel was injected into the abdominal subcutaneously tissue of EC null mice and wild type control littermates along the peritoneal mid-line, with 10 mice per group. At day 8, mice were sacrificed and plugs were removed and proceed for histology. Typically, the overlying skin was removed, and the gel were cut out and fixed in 4% paraformaldehyde in PBS, and embedded in paraffin. 5 µm sections were cut and stained with Masson Trichrome staining.
Wound healing
Wound healing experiment was performed to the mice 8 weeks after bone marrow transplantation. 14 weeks old sex-and age-matched mice were used in the experiment with 5 males and 5 females per group. The detail procedure was followed as previously described [54] . The wounds were collected and preceded as described below for immunohistochemical analysis.
Tumorigenesis
A total of 8 X10
6
Lewis lung carcinomas cells (ATCC) were injected subcutaneously into EC null mice and wild type control littermates 8 weeks after bone marrow transplantation. Tumors were removed from 8 WT and 9 EC null mice, 15 days postinjection. Each tumor was weighted and then separated in two halves, one was freshly frozen for cryosections, and the other half was fixed at 4% methanol free paraformaldehyde solution for paraffin embedding. Tumor sections were processed as described below for immunohistochemical analysis.
Immunohistochemical analysis
For paraffin sections, the tissues were fixed for overnight at 4°C with 4% methanol free paraformaldehyde solution prior to paraffin wax embedding, sectioning and staining with
Hematoxylin and Eosin or Masson-Trichome staining. For frozen section, tissues were freshly frozen in OCT on dry ice. For detecting the hypoxic area of wounds and tumors, mice were injected i.p. with 60mg/kg (in w/v PBS) pimonidazole, 1.5hr prior to sacrifice.
The details were described previously (Blouw et al 2003) . For CD31 staining, frozen sections were processed as previously described (Ryan, et al, 2000) . For CD31 and BrdU double staining, mice were injected i.p. with 0.1ml/10g BrdU (Amersham Bioscience), 2 hr prior to sacrifice. The staining was performed on frozen sections. After CD31 staining was developed, antigen retrieval was performed on the sections using 1X citrate buffer followed by overnight incubation at room temperature of a 1:20 dilution of biotinlyatedanti-mouse Brdu antibody (Molecular probe). Staining was visualized via the ABC Elite staining kit (Vector Laboratories) using DAB as a substrate or ABC alkaline phosphatase kit using Vector Blue as a substrate. Vascular density in the most vascular regions of the wounds was determined with a Chalkley eyepiece graticule as described by Fox et al [55] . Vascular density in the matrigel plugs and tumors was determined with Image J software.
FACScan analysis:
Monolayers Statistical analysis was performed using the unpaired Student's test. 
